96 related articles for article (PubMed ID: 10811992)
1. Prognostic significance of hTERT expression in non-small cell lung cancer.
Komiya T; Kawase I; Nitta T; Yasumitsu T; Kikui M; Fukuoka M; Nakagawa K; Hirashima T
Int J Oncol; 2000 Jun; 16(6):1173-7. PubMed ID: 10811992
[TBL] [Abstract][Full Text] [Related]
2. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
3. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer.
Hara H; Yamashita K; Shinada J; Yoshimura H; Kameya T
Lung Cancer; 2001 Nov; 34(2):219-26. PubMed ID: 11679180
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.
Miura N; Nakamura H; Sato R; Tsukamoto T; Harada T; Takahashi S; Adachi Y; Shomori K; Sano A; Kishimoto Y; Ito H; Hasegawa J; Shiota G
Cancer Sci; 2006 Dec; 97(12):1366-73. PubMed ID: 17052260
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic value of hTERT mRNA expression in patients with non-small-cell lung cancer.
Zalewska-Ziob M; Dobija-Kubica K; Biernacki K; Adamek B; Kasperczyk J; Bruliński K; Ostrowska Z
Acta Biochim Pol; 2017; 64(4):641-646. PubMed ID: 29141053
[TBL] [Abstract][Full Text] [Related]
8. [Relationships among expressions of hTERT, MDR1, MRP mRNA, and C-myc protein in non-small cell lung cancer].
Li L; Xiong YY; Liu L; Chen TX; Yao XF; Wang YW
Ai Zheng; 2005 Jan; 24(1):53-7. PubMed ID: 15642200
[TBL] [Abstract][Full Text] [Related]
9. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
[TBL] [Abstract][Full Text] [Related]
10. Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas.
Wu TC; Lin P; Hsu CP; Huang YJ; Chen CY; Chung WC; Lee H; Ko JL
Lung Cancer; 2003 Aug; 41(2):163-9. PubMed ID: 12871779
[TBL] [Abstract][Full Text] [Related]
11. Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
Geng Z; Zhang D; Liu Y
Chin Med J (Engl); 2003 Oct; 116(10):1467-70. PubMed ID: 14570602
[TBL] [Abstract][Full Text] [Related]
12. Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.
Pelosi G; Schianchi E; Dell'orto P; Veronesi G; Spaggiari L; Pasini F; Sozzi G; Brambilla E; Griso C; Viale G
Virchows Arch; 2006 Jan; 448(1):7-15. PubMed ID: 16193293
[TBL] [Abstract][Full Text] [Related]
13. Prognostic potential of the telomerase subunit human telomerase reverse transcriptase in tumor tissue and nontumorous mucosa from patients with colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Werner M; Lassmann S; Ulm K; Nekarda H; Siewert JR
Cancer; 2002 Nov; 95(10):2103-11. PubMed ID: 12412163
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.
Van den Berg RM; Brokx H; Vesin A; Field JK; Brambilla C; Meijer CJ; Sutedja GT; Heideman DA; Postmus PE; Smit EF; Snijders PJ
Int J Oncol; 2010 Aug; 37(2):455-61. PubMed ID: 20596673
[TBL] [Abstract][Full Text] [Related]
15. hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.
Wang L; Soria JC; Kemp BL; Liu DD; Mao L; Khuri FR
Clin Cancer Res; 2002 Sep; 8(9):2883-9. PubMed ID: 12231532
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
17. Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation.
Marchetti A; Pellegrini C; Buttitta F; Falleni M; Romagnoli S; Felicioni L; Barassi F; Salvatore S; Chella A; Angeletti CA; Roncalli M; Coggi G; Bosari S
Lab Invest; 2002 Jun; 82(6):729-36. PubMed ID: 12065683
[TBL] [Abstract][Full Text] [Related]
18. Expression of human telomerase subunit genes in primary lung cancer and its clinical significance.
Arinaga M; Shimizu S; Gotoh K; Haruki N; Takahashi T; Takahashi T; Mitsudomi T
Ann Thorac Surg; 2000 Aug; 70(2):401-5; discussion 405-6. PubMed ID: 10969652
[TBL] [Abstract][Full Text] [Related]
19. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
Hsu CP; Hsu NY; Lee LW; Ko JL
Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
